PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using Monoclonal Mouse Anti-PD-L1, Clone 22C3 intended for use in the detection of PD-L1 protein in formalin-fixed, paraffin-embedded (FFPE) Ovarian Carcinoma tissue using EnVision FLEX visualization system on Autostainer Link 48.
PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients with ovarian carcinoma (epithelial ovarian, fallopian tube, or primary peritoneal carcinoma) whose tumors express PD-L1 (CPS>1) for treatment with pembrolizumab.
Stain-only (tech-only) testing is available to clients who have completed the test kit manufacturers online interpretation training. For other tests for this indication, please search our Test Menu for Ovarian to see available options.